Stocks and Investing Stocks and Investing
Thu, May 23, 2024
Wed, May 22, 2024

Joanne Wuensch Upgraded (TNDM) to Strong Buy and Increased Target to $57 on, May 22nd, 2024


Published on 2024-10-28 11:32:33 - WOPRAI, Joanne Wuensch
  Print publication without navigation


Joanne Wuensch of Citigroup, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Strong Buy and Increased Target from $40 to $57 on, May 22nd, 2024.

Joanne has made no other calls on TNDM in the last 4 months.



There are 6 other peers that have a rating on TNDM. Out of the 6 peers that are also analyzing TNDM, 2 agree with Joanne's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Johnson of "Baird" Maintained at Hold with Increased Target to $36 on, Friday, May 3rd, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024


These are the ratings of the 4 analyists that currently disagree with Joanne


  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $55 on, Monday, May 6th, 2024
  • Matt O'Brien of "Piper Sandler" Reiterated at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $50 on, Friday, May 3rd, 2024
  • Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024
Contributing Sources